National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 385-386 [2017-28417]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 2 / Wednesday, January 3, 2018 / Notices
Research Misconduct notice published
on November 27, 2017.
FOR FURTHER INFORMATION CONTACT:
Ms.
Karen Gorirossi at 240–453–8800.
I. Background
In FR Doc. 2017–25549 of November
27, 2017 (82 FR 56042–56043), there
was a referencing error involving
incorrect citation of a paper in the
notice. The error is identified and
corrected in the Correction of Errors
section below.
II. Correction of Errors
sradovich on DSK3GMQ082PROD with NOTICES
In FR Doc. 2017–25549 of November
27, 2017 (82 FR 56042–56043), make the
following corrections:
1. On page 56042, third column, in FR
Doc. 2017–25549, last paragraph, lines
16–26, and page 56043, first paragraph,
lines 1–5, delete ‘‘Respondent engaged
in research misconduct at ESOM and
falsified RT–PCR data on Excel
spreadsheets in the research record and
in a figure generated from the false data
included in a manuscript submitted to
and withdrawn from Scientific Reports
(‘‘Immipramine Blue Sensitively and
Selectively Targets FLT3–ITD Positive
Acute Myeloid Leukemia Cells.’’
Scientific Reports 7(1):4447, 2017 June
30; doi:10.1038/s41598–017–04796–1.
PMID: 28667329. Submitted to
Scientific Reports [withdrawn];
hereafter referred to as the ‘‘Scientific
Reports manuscript’’)’’ and replace with
the following text: ‘‘Respondent engaged
in research misconduct at ESOM and
falsified RT–PCR data on Excel
spreadsheets in the research record and
in a figure generated from the false data
included in an unpublished manuscript
submitted to and withdrawn from
Scientific Reports [withdrawn];
hereafter referred to as the ‘‘Scientific
Reports manuscript.’’ ’’
2. On page 56043, first column, in FR
Doc. 2017–25549, fourth paragraph
(second bullet), lines 6–7, insert
‘‘unpublished’’ before ‘‘Scientific
Reports’’ so that the text reads:
‘‘included false data in the unpublished
Scientific Reports manuscript.’’
Dated: December 20, 2017.
Wanda K. Jones,
Interim Director, Office of Research Integrity.
BILLING CODE 4150–31–P
VerDate Sep<11>2014
16:13 Jan 02, 2018
Jkt 244001
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
SUPPLEMENTARY INFORMATION:
[FR Doc. 2017–28409 Filed 1–2–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: January 24, 2018.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room E1/E2, 45 Center
Drive, Bethesda, MD 20892.
Closed: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room E1/E2, 45 Center
Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Acting Director, Division of Extramural
Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707
Democracy Blvd., Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594–4757,
malikk@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Kidney, Urologic and Hematologic
Diseases.
Date: January 24, 2018.
Open: 1:00 p.m. to 3:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
385
Center), Conference Room F1/F2, 45 Center
Drive, Bethesda, MD 20892.
Closed: 3:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room F1/F2, 45 Center
Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Acting Director, Division of Extramural
Activities, National Institutes of Diabetes and
Digestive and Kidney Diseases, 6707
Democracy Blvd., Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594–4757,
malikk@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology and
Metabolic Diseases.
Date: January 24, 2018.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate to review
the Division’s scientific and planning
activities.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room E1/E2, 45 Center
Drive, Bethesda, MD 20892.
Closed: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room E1/E2, 45 Center
Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Acting Director, Division of Extramural
Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707
Democracy Blvd., Room, 7329, MSC 5452,
Bethesda, MD 20892, (301) 594–4757,
malikk@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition.
Date: January 24, 2018.
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Natcher Building (Natcher Conference
Center), Conference Room D, 45 Center Drive,
Bethesda, MD 20892.
Closed: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place:National Institutes of Health, Natcher
Building (Natcher Conference Center),
Conference Room D, 45 Center Drive,
Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Acting Director, Division of Extramural
Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707
Democracy Blvd. Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594–4757,
malikk@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
E:\FR\FM\03JAN1.SGM
03JAN1
386
Federal Register / Vol. 83, No. 2 / Wednesday, January 3, 2018 / Notices
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 28, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28417 Filed 1–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Neuroscience of
Aging Review Committee; NIA—N.
Date: February 1–2, 2018.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Building, Suite
2W200, Bethesda, MD 20892, 301–402–1622,
bissonettegb@mail.nih.gov.
VerDate Sep<11>2014
16:13 Jan 02, 2018
Jkt 244001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 28, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28415 Filed 1–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS 2018—Topic 60:
Computational Software Development to
Advance Translational Research for
Infectious Diseases.
Date: January 25, 2018.
Time: 12:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer Scientific Review
Program, Division of Extramural Activities,
Room 3G62A, National Institute of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5081,
ecohen@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS 2018–1: Small Business
Innovation Research (SBIR) Program Contract
Solicitation (Topic 52) (N01).
Date: January 26, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Vasundhara Varthakavi,
DVM, Ph.D., Scientific Review Officer
Scientific Review Program, Division of
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Extramural Activities, Room 3E70, National
Institutes of Health, NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5020, varthakaviv@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; (PHS–2016–1) Small
Business Innovation Research (SBIR) ‘‘Topics
37 and 38: ‘‘Phase II Program Contract
Solicitation’’.
Date: January 26, 2018.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Ellen S. Buczko, Ph.D.,
Scientific Review Officer Scientific Review
Program, Division of Extramural Activities,
Room # 3F30A National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5028,
ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28338 Filed 1–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: January 30, 2018.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Alexandrian, 480 King Street,
Alexandria, VA 22314.
E:\FR\FM\03JAN1.SGM
03JAN1
]]>Agencies
[Federal Register Volume 83, Number 2 (Wednesday, January 3, 2018)]
[Notices]
[Pages 385-386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28417]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Diabetes
and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: January 24, 2018.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room E1/E2, 45 Center Drive,
Bethesda, MD 20892.
Closed: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room E1/E2, 45 Center Drive,
Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Acting Director, Division
of Extramural Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Kidney, Urologic and Hematologic
Diseases.
Date: January 24, 2018.
Open: 1:00 p.m. to 3:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room F1/F2, 45 Center Drive,
Bethesda, MD 20892.
Closed: 3:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room F1/F2, 45 Center Drive,
Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Acting Director, Division
of Extramural Activities, National Institutes of Diabetes and
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Diabetes, Endocrinology and Metabolic
Diseases.
Date: January 24, 2018.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate to review the Division's
scientific and planning activities.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room E1/E2, 45 Center Drive,
Bethesda, MD 20892.
Closed: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room E1/E2, 45 Center Drive,
Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Acting Director, Division
of Extramural Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707 Democracy Blvd., Room, 7329,
MSC 5452, Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Digestive Diseases and Nutrition.
Date: January 24, 2018.
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room D, 45 Center Drive, Bethesda, MD
20892.
Closed: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place:National Institutes of Health, Natcher Building (Natcher
Conference Center), Conference Room D, 45 Center Drive, Bethesda, MD
20892.
Contact Person: Karl F. Malik, Ph.D., Acting Director, Division
of Extramural Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707 Democracy Blvd. Room 7329, MSC
5452, Bethesda, MD 20892, (301) 594-4757, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
[[Page 386]]
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm.,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: December 28, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-28417 Filed 1-2-18; 8:45 am]
BILLING CODE 4140-01-P
